| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6119476 | Journal of Clinical Virology | 2016 | 5 Pages |
Abstract
2013/2014 IIV3 and LAIV4 recipients had consistently lower MN antibody titers against H1N1-14 compared with H1N1-09. The HA K166Q mutation, located in a neutralizing epitope, probably contributed to these findings.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Michelle A. Barron, Daniel N. Frank, David Claypool, Diana Ir, Mariangeli F. Ning, Donna Curtis, Adriana (Professor of Pediatrics, Medicine and Pathology, Director),